BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PTCMA - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PTCMA
X-ORIGINAL-URL:https://ptcma.org.za
X-WR-CALDESC:Events for PTCMA
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Africa/Johannesburg
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0200
TZNAME:SAST
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Africa/Johannesburg:20250521T183000
DTEND;TZID=Africa/Johannesburg:20250521T200000
DTSTAMP:20250505T124117Z
CREATED:20250307T113857Z
LAST-MODIFIED:20250505T124117Z
UID:12371-1747852200-1747857600@ptcma.org.za
SUMMARY:Evening Virtual CPD - 21 May 2025
DESCRIPTION:Programme\n18h45: Login and sound check \n19h00: The Evolving Treatment Landscape in Unresectable or Metastatic HER2-Positive Breast Cancer \nPresented by: Dr Keo Tabane (Medical Oncologist) \n  \n\n\n\n\nClick to register\n\n\n\n\n\n\nThank you to AstraZeneca for providing the unconditional educational sponsorship\, making this session possible.
URL:https://ptcma.org.za/event/evening-virtual-cpd-21-may-2025/
CATEGORIES:Evening,VCPD
ATTACH;FMTTYPE=image/jpeg:https://ptcma.org.za/wp-content/uploads/2024/01/Breast-cancer-600wx400.jpg
END:VEVENT
END:VCALENDAR